IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR-ABL1-dependent IL-6 expression by CML cells, for example, led to the establishment of a proinflammatory tumor environment and—via an autocrine activation loop—sustained CML development [152].